OSR Health OSRHW
NASDAQ OSRHW
$0.05 +0.01 (+40.73%)
As of: Aug 24, 2026 · 3:58 PM EDT

OSR Health (OSRHW) Retained Earnings (2021 - 2026)

OSR Health (OSRHW) posted Retained Earnings of -$1.7 million for Q1 2026, up 95.53% sequentially from -$37.2 million in Q4 2025, and up 94.57% YoY from -$853600.5 in Q1 2025.

OSR Health (OSRHW) Retained Earnings (2021 - 2026) Analysis & Trends

OSR Health has reported Retained Earnings for 6 years, with the latest figure at -$1.7 million in Q1 2026.

  • Quarterly Retained Earnings rose 94.57% year-over-year to -$1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.7 million (up 94.57% YoY) and the FY2025 annual result came in at -$37.2 million, down 93.87% from the prior year.
  • Retained Earnings advanced to -$1.7 million in Q1 2026 per OSRHW's latest filing, from -$37.2 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $4.7 million in Q3 2025 and troughed at -$37.2 million in Q4 2025.
  • A 5-year average of -$10.7 million and a median of -$3.2 million in 2023 frame the typical range for Retained Earnings.
  • The sharpest annual moves came in 2023 and 2026: Retained Earnings plunged 6150.41% in 2023, then soared 94.57% in 2026.
  • Over 5 years, Retained Earnings stood at -$62508.0 in 2022, then slumped by 6150.41% to -$3.9 million in 2023, then sank by 390.74% to -$19.2 million in 2024, then tumbled by 93.87% to -$37.2 million in 2025, then surged by 95.53% to -$1.7 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$1.7 million, -$37.2 million, and $4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.97 Bn 131.12 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.15 Bn 77.15 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 62.84 Bn 57.65 Bn 1.37 Bn 558.00 Mn
4 Moderna 55.74 Bn 50.60 Bn 52.00 Mn 5.10 Bn
5 BeOne Medicines 41.53 Bn 36.43 Bn 1.53 Bn 13.05 Bn
6 Alnylam Pharmaceuticals 31.60 Bn 28.29 Bn 992.69 Mn -6.33 Bn
7 BioNTech SE 27.32 Bn 8.93 Bn 668.28 Mn 20.91 Bn
8 Royalty Pharma 27.29 Bn 26.45 Bn - 4.38 Bn
9 Insmed 26.99 Bn 25.83 Bn 358.27 Mn 6.57 Bn
10 OSR Health 1.40 Mn 20.39 Mn 86,605.00 -40.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.66 Mn
Dec 31, 2025 -37.17 Mn
Sep 30, 2025 4.72 Mn
Jun 30, 2025 -30.18 Mn
Mar 31, 2025 -30.57 Mn
Dec 31, 2024 -19.17 Mn
Mar 31, 2024 -4.31 Mn
Dec 31, 2023 -3.91 Mn
Sep 30, 2023 -2.46 Mn
Jun 30, 2023 -2.09 Mn
Mar 31, 2023 -1.83 Mn
Dec 31, 2022 -62,508.00
Dec 31, 2021 -27,120.00